A number of previous and more recent studies have shown that STAT5 activation is a critical event triggering oncogenesis in MPN (stem) cells and that mutated forms of JAK2 and CALR can induce STAT5 activation [22,23,24,25]. This evidence concerns the gene STAT5B and myeloproliferative disorder.